| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-14 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.33 | 4e-14 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-12 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-10 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.29 | 7e-10 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-09 |